Molecular dissection of allergen sensitisation and immunotherapy: direct application to precision medicine in treatment of asthma [ 1/1/2021 - 12/31/2024 ]

Research Grant

Brief description Asthma is a major global health burden with huge socioeconomic impact. Most asthmatic patients are allergic. Allergen immunotherapy is the only treatment to alter the natural disease course, but does not work in many treated patients, and robust laboratory biomarkers for patient selection and immune monitoring of treatment success are lacking. Therefore, allergen immunotherapy is not offered to most patients who then rely on medications indefinitely. This research will address these needs.

Funding Amount $1,270,097

Funding Scheme Ideas Grants

Chief Investigator A/Pr Menno van Zelm

Notes Ideas Grants